- Home
- AXR vs PRE Comparison
AXR vs PRE Comparison
Compare AXR & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXR
- PRE
- Stock Information
- Founded
- AXR 1961
- PRE 2014
- Country
- AXR United States
- PRE Hong Kong
- Employees
- AXR N/A
- PRE N/A
- Industry
- AXR Homebuilding
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- AXR Real Estate
- PRE Industrials
- Exchange
- AXR Nasdaq
- PRE Nasdaq
- Market Cap
- AXR 127.3M
- PRE 131.3M
- IPO Year
- AXR N/A
- PRE N/A
- Fundamental
- Price
- AXR $20.95
- PRE $12.32
- Analyst Decision
- AXR
- PRE Buy
- Analyst Count
- AXR 0
- PRE 1
- Target Price
- AXR N/A
- PRE $32.00
- AVG Volume (30 Days)
- AXR 7.4K
- PRE 188.9K
- Earning Date
- AXR 12-12-2025
- PRE 11-10-2025
- Dividend Yield
- AXR N/A
- PRE N/A
- EPS Growth
- AXR 40.98
- PRE N/A
- EPS
- AXR 2.48
- PRE N/A
- Revenue
- AXR $48,454,000.00
- PRE $57,051,000.00
- Revenue This Year
- AXR $28.57
- PRE $202.46
- Revenue Next Year
- AXR N/A
- PRE $103.60
- P/E Ratio
- AXR $8.40
- PRE N/A
- Revenue Growth
- AXR N/A
- PRE 256.82
- 52 Week Low
- AXR $17.60
- PRE $3.10
- 52 Week High
- AXR $39.68
- PRE $17.99
- Technical
- Relative Strength Index (RSI)
- AXR 32.74
- PRE 44.20
- Support Level
- AXR $22.34
- PRE $12.05
- Resistance Level
- AXR $21.49
- PRE $13.89
- Average True Range (ATR)
- AXR 1.01
- PRE 1.42
- MACD
- AXR -0.30
- PRE -0.47
- Stochastic Oscillator
- AXR 16.46
- PRE 11.91
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.